Estimates of Peripartum and Postnatal Mother-to-child Transmission Probabilities of HIV for Use in Spectrum and Other Population-based Models

Overview

Journal Sex Transm Infect

Specialty Infectious Diseases

Date 2012 Nov 23

PMID 23172345

Citations 35

Authors

Nigel Rollins

Mary Mahy

Renaud Becquet

Louise Kuhn

Tracy Creek

Lynne Mofenson

Affiliations

Soon will be listed here.

Abstract

Background: The Global Plan Towards the Elimination of New HIV Infections among Children and Keeping Their Mothers Alive aims to reduce by 2015 the number of new infections in children, in 22 priority countries, by at least 90% from 2009 levels. Mathematical models, such as Spectrum, are used to estimate national and global trends of the number of infants infected through mother-to-child transmission (MTCT). However, other modelling exercises have also examined MTCT under different settings. MTCT probabilities applied in models to populations that are assumed to receive antiretroviral interventions need to reflect the most current risk estimates.

Methods: The UNAIDS Reference Group on Estimates, Modelling and Projections held a consultation to review data on MTCT probabilities. Published literature, recent conferences and data from personal communications with principle investigators were reviewed. Based on available data, peripartum and postnatal transmission probabilities were estimated for different antiretroviral drug regimens and maternal CD4 levels including for women with incident infection.

Results: Incident infections occurring during pregnancy are estimated to be associated with a 30% probability of MTCT; incident infections during breast feeding lead to a 28% probability of postnatal MTCT. The 2010 WHO recommended regimens (Options A or B) are estimated to be associated with a 2% peripartum transmission probability and 0.2% transmission probability per month of breast feeding. Peripartum and postnatal transmission probabilities were lowest for women who were taking antiretroviral therapy before the pregnancy namely 0.5% peripartum and 0.16% per month of breast feeding, respectively.

Discussion: These updated probabilities of HIV transmission (applied to Spectrum in April 2011) will be used to estimate new child HIV infections and track progress towards the 2015 targets of the Global Plan.

Citing Articles

Probability of vertical HIV transmission: A systematic review and meta-regression.

Walters M, Bulterys M, Barry M, Louden D, Hicks S, Richey A medRxiv. 2024; .

PMID: 39677422 PMC: 11643157. DOI: 10.1101/2024.12.03.24318418.

Projected impact of fast-tracking of anti-retroviral treatment coverage on vertical transmission of HIV in India.

Kumar P, Das C, Biswas S, Priyam N, Kharayat L, Sahu D PLOS Glob Public Health. 2024; 4(9):e0003702.

PMID: 39292653 PMC: 11410226. DOI: 10.1371/journal.pgph.0003702.

Guidance for Triangulating Data and Estimates of HIV Prevalence Among Pregnant Women and Coverage of PMTCT Using the Spectrum AIDS Impact Module.

Walters M, Korenromp E, Yakusik A, Wanyeki I, Kabore A, Poimouribou A J Acquir Immune Defic Syndr. 2024; 97(5):439-449.

PMID: 39187933 PMC: 11540279. DOI: 10.1097/QAI.0000000000003514.

Differences in Breastfeeding Duration by Maternal HIV Status: A Pooled Analysis of Nationally Representative Surveys in Sub-Saharan Africa.

Glaubius R, Stover J, Johnson L, Mahiane S, Mahy M, Eaton J J Acquir Immune Defic Syndr. 2024; 95(1S):e81-e88.

PMID: 38180741 PMC: 10769179. DOI: 10.1097/QAI.0000000000003317.

Augmenting progress on the elimination of vertical transmissions of HIV in India: Insights from Spectrum-based HIV burden estimations.

Kumar P, Das C, Das U, Kumar A, Priyam N, Ranjan V PLOS Glob Public Health. 2023; 3(8):e0002270.

PMID: 37556441 PMC: 10411776. DOI: 10.1371/journal.pgph.0002270.

References

Tonwe-Gold B, Ekouevi D, Viho I, Amani-Bosse C, Toure S, Coffie P . Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med. 2007; 4(8):e257. PMC: 1949842. DOI: 10.1371/journal.pmed.0040257. View

Wiktor S, Ekpini E, Karon J, Nkengasong J, Maurice C, Severin S . Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet. 1999; 353(9155):781-5. DOI: 10.1016/S0140-6736(98)10412-9. View

Thomas T, Masaba R, Borkowf C, Ndivo R, Zeh C, Misore A . Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 2011; 8(3):e1001015. PMC: 3066129. DOI: 10.1371/journal.pmed.1001015. View

Hoffman R, Black V, Technau K, van der Merwe K, Currier J, Coovadia A . Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010; 54(1):35-41. PMC: 2880466. DOI: 10.1097/QAI.0b013e3181cf9979. View

Chasela C, Hudgens M, Jamieson D, Kayira D, Hosseinipour M, Kourtis A . Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010; 362(24):2271-81. PMC: 3440865. DOI: 10.1056/NEJMoa0911486. View

Shapiro R, Hughes M, Ogwu A, Kitch D, Lockman S, Moffat C . Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010; 362(24):2282-94. PMC: 2999916. DOI: 10.1056/NEJMoa0907736. View

Roongpisuthipong A, Siriwasin W, Simonds R, Sangtaweesin V, Vanprapar N, Wasi C . HIV seroconversion during pregnancy and risk for mother-to-infant transmission. J Acquir Immune Defic Syndr. 2001; 26(4):348-51. DOI: 10.1097/00126334-200104010-00011. View

Iliff P, Piwoz E, Tavengwa N, Zunguza C, Marinda E, Nathoo K . Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005; 19(7):699-708. DOI: 10.1097/01.aids.0000166093.16446.c9. View

Barker P, Mphatswe W, Rollins N . Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2010; 56(2):e45-8. DOI: 10.1097/QAI.0b013e3181fdbf20. View

10.

. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002; 359(9313):1178-86. DOI: 10.1016/S0140-6736(02)08214-4. View

11.

Lallemant M, Jourdain G, Le Coeur S, Mary J, Ngo-Giang-Huong N, Koetsawang S . Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004; 351(3):217-28. DOI: 10.1056/NEJMoa033500. View

12.

Rollins N, Little K, Mzolo S, Horwood C, Newell M . Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS. 2007; 21(10):1341-7. DOI: 10.1097/QAD.0b013e32814db7d4. View

13.

Coovadia H, Rollins N, Bland R, Little K, Coutsoudis A, Bennish M . Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007; 369(9567):1107-16. DOI: 10.1016/S0140-6736(07)60283-9. View

14.

Dabis F, Bequet L, Ekouevi D, Viho I, Rouet F, Horo A . Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005; 19(3):309-18. PMC: 2474891. View

15.

Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F . Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?. AIDS. 2005; 19(16):1865-75. DOI: 10.1097/01.aids.0000188423.02786.55. View

16.

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

17.

Peltier C, Ndayisaba G, Lepage P, van Griensven J, Leroy V, Pharm C . Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS. 2009; 23(18):2415-23. PMC: 3305463. DOI: 10.1097/QAD.0b013e32832ec20d. View

18.

Ekpini E, Wiktor S, Satten G, Sibailly T, Ou C, Karon J . Late postnatal mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire. Lancet. 1997; 349(9058):1054-9. DOI: 10.1016/s0140-6736(96)06444-6. View

19.

Dunn D, Newell M, Ades A, Peckham C . Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992; 340(8819):585-8. DOI: 10.1016/0140-6736(92)92115-v. View

20.

Birkhead G, Pulver W, Warren B, Hackel S, Rodriguez D, Smith L . Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 2002-2006. Obstet Gynecol. 2010; 115(6):1247-1255. DOI: 10.1097/AOG.0b013e3181e00955. View